Comprehensive Care Fueled by Leading Research
Movement disorders affect the speed, fluency, quality, and ease of movement. They can result in excessive or slowed movements.
Our team at UT Southwestern handles more than 4,000 patient visits a year, offering state-of-the-art care for a wide range of movement disorders, such as:
Our Services for Movement Disorders
The UT Southwestern Movement Disorders team includes fellowship-trained neurologists, neurosurgeons, advanced practice professionals, and other health care professionals with specific expertise in these neurological disorders.
UT Southwestern offers patients with movement disorders:
- Access to clinical research programs and investigational drugs
- Botulinum toxin treatments
- The latest diagnostic imaging approaches
- Information and support for family members
- Physical, speech, and occupational therapy
- Nutrition counseling
- Mental health support
- The latest medical therapies
- Deep brain stimulation (DBS)
- High-frequency ultrasound treatment of tremor
- Support services such as the Total Care Program for Parkinson's Disease
Rehabilitation
Our rehabilitation specialists provide compassionate, individualized therapies that can help ease symptoms and slow the progression of many movement disorders.
Our rehabilitation team includes nurses, neuropsychologists, psychologists, and occupational, physical, recreational, and speech therapists, so that patients benefit from a comprehensive program that addresses all aspects of their disease. Our exercise and rehabilitation program enables patients to continue participating in activities at work, at home, and in their community.
Our specialists also work diligently with family members, offering psychological counseling, support groups, educational programs, and other services.
Clinical Trials
As a world-class academic medical center, UT Southwestern offers patients with movement disorders unique access to research, clinical trials, and new therapies – often before they’re available at other hospitals.
Our Movement Disorders team has led extensive research programs to investigate the genetic and other contributing factors of movement disorders. This includes several long-term National Institutes of Health (NIH)-funded trials designed to identify neuroprotective agents for Parkinson's disease.